You may love weed, alcohol, and tobacco, but would you also like to invest in those things? AdvisorShares thinks you will. The actively managed exchange-traded funds company recently launched AdvisorShares VICE ETF, the only ETF solely concentrating on companies associated with alcohol, cannabis, and tobacco.
Dan Ahrens is a Managing Director and Portfolio Manager at AdvisorShares, and he joins Cheddar to explain why investing in the VICE ETF is a good idea. Ahrens explains that those three industries tend to be stable despite the general market volatility. Ahrens is also bullish on the future of cannabis. He believes the legalization and federal recognition of the substance will only expand.
As for alcohol, there has also been growth in that field. The alcohol industry had supplier revenue increase by 4.5% to $25.2 billion last year. Ahrens anticipates the field to continue improving.
Student loan borrowers have the ability to earn retirement funds pegged to their payments – and the company Summer might be bringing it to your workplace.
It might not be what investors want to hear… but bringing down inflation could mean interest rates stay higher for (even) longer. But it's not all downside.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.